iclaprim has been researched along with trimethoprim, sulfamethoxazole drug combination in 2 studies
| Studies (iclaprim) | Trials (iclaprim) | Recent Studies (post-2010) (iclaprim) | Studies (trimethoprim, sulfamethoxazole drug combination) | Trials (trimethoprim, sulfamethoxazole drug combination) | Recent Studies (post-2010) (trimethoprim, sulfamethoxazole drug combination) |
|---|---|---|---|---|---|
| 45 | 7 | 16 | 7,527 | 875 | 2,260 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Karlowsky, JA; Zhanel, GG | 1 |
| Entenza, JM; Giddey, M; Haldimann, A; Hawser, S; Lociuro, S; Moreillon, P | 1 |
2 other study(ies) available for iclaprim and trimethoprim, sulfamethoxazole drug combination
| Article | Year |
|---|---|
In vitro activity of Iclaprim against respiratory and bacteremic isolates of Streptococcus pneumoniae.
Topics: Bacteremia; Drug Resistance, Bacterial; Humans; Microbial Sensitivity Tests; Pyrimidines; Respiratory System; Streptococcus pneumoniae; Trimethoprim, Sulfamethoxazole Drug Combination | 2009 |
Efficacy of iclaprim against wild-type and thymidine kinase-deficient methicillin-resistant Staphylococcus aureus isolates in an in vitro fibrin clot model.
Topics: Animals; Anti-Bacterial Agents; Humans; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Mutation; Pyrimidines; Rats; Thymidine Kinase; Trimethoprim, Sulfamethoxazole Drug Combination; Vancomycin | 2009 |